Specific measures of a tumor’s texture and intensity as they appear on CT images can help determine how much treatment patients with early stage lung cancer need, a study found.
Beth Incollingo
Advertisement
Articles by Beth Incollingo
Yescarta was granted FDA approval for use in adults with relapsed or refractory non-Hodgkin lymphoma. This is only the second CAR T-cell therapy ever approved.
Advertisement
Latest Updated Articles
CAR T-Cell Therapy Yescarta Approved to Treat Non-Hodgkin LymphomaPublished: October 19th 2017 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Trodelvy Plus Keytruda Upholds Quality of Life in TNBC
2
ADC Use Rapidly Growing in Metastatic Breast Cancer Treatment
3
Cancer Vaccine Plus Keytruda Slow Advanced Melanoma Progression
4
Camrelizumab Combo Extends Survival in Metastatic Cervical Cancer
5
